Reimbursement

In Germany, NUB-1 status has again been granted for the transcatheter implantation of an interatrial shunt device for the treatment of heart failure for calendar year 2022.

If your hospital submitted a corresponding NUB application, you may now negotiate a NUB budget for the implantation of the Corvia^® Atrial Shunt System (IASD^®). Corvia Medical has developed an NUB Handbook that contains important information regarding the procedure, the clinical data, and the cost of the Corvia Atrial Shunt to support successful reimbursement efforts. If you would like a copy of the NUB Handbook, if you have questions or would like reimbursement support, please contact us at EuropeanReimbursement@corviamedical.com.

Das Corvia Atrial Shunt System erhält den NUB Status 1 für 2022 in Deutschland.
Weitere Informationen.

Download